NASDAQFinancialsAsset ManagementSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for GROW yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS improves to at least $0.21 by Q3 2026 | A primary condition in US Global Investors Inc's published investment case. The stated target is >= $0.21. | Intact | EPS falls below $0.02 in any quarter through 2026-Q3 | Diluted EPS: $-0.02 per share FY2026-Q4; GAAP. Published target: >= $0.21. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Sep 3, 2026-0.0229 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a small-cap financial business with a fragile earnings record, rather than a proven, steady compounder. The long-term thesis is on watch: revenue has grown in the reported quarters, but net income delivery has been mixed and confidence has eased to medium.
GROW is described as cheap versus peers, and the valuation model shows a negative expectations gap, meaning expectations appear restrained. The valuation evidence is medium confidence, and the priced-in assessment says weak execution is reflected without a broader high-fragility setup.
Near term, the risk of an earnings miss is elevated, with a run of consecutive misses and small-company volatility cited as reasons. Revenue rose through 2026-Q3, but net income shifted between profit and loss in the reported quarters; management’s focus on revenue and earnings growth has therefore produced mixed results so far.
The near-term case weakens if management cuts guidance or if rate cuts weigh on financial-sector conditions. Sector momentum could provide support if bellwethers such as BLK, BX, and KKR continue to report strong earnings and raise guidance. Over the multi-year view, the key question is whether revenue growth can translate into more consistent net income and earnings per share.
Over the next 1 to 3 years, GROW’s thesis depends on converting revenue gains into reliable profits, while near-term execution and sector risks remain elevated. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Net income grows to at least $2.7 million by Q3 2026 |
| Net income improved from $315K to $2.7M, showing strong profit growth. |
| Intact |
| net income falls below $315K in any quarter through 2026-Q3 |
Net income: $-283,000 FY2026-Q4; GAAP. Published target: >= $2.7 million. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Sep 3, 2026-283,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows to at least $2.76 million by Q3 2026 | A primary condition in US Global Investors Inc's published investment case. The stated target is >= $2.76 million. | Intact | revenue falls below $2.16 million in any quarter through 2026-Q3 | Revenue: $-452,000 FY2026-Q4; GAAP. Published target: >= $2.76 million. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Sep 3, 2026-452,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.